CoChat

Physiologically-Based Pharmacokinetics in Drug Development and Regulatory Science

Rowland, Malcolm, Peck, Carl, Tucker, Geoffrey · 2011 · Annual Review of Pharmacology and Toxicology

The DOI matches its Crossref record; 199 of the 199 references it cites were found in a registry or an index.

Abstract

The application of physiologically-based pharmacokinetic (PBPK) modeling is coming of age in drug development and regulation, reflecting significant advances over the past 10 years in the predictability of key pharmacokinetic (PK) parameters from human in vitro data and in the availability of dedicated software platforms and associated databases. Specific advances and contemporary challenges with respect to predicting the processes of drug clearance, distribution, and absorption are reviewed, together with the ability to anticipate the quantitative extent of PK-based drug-drug interactions and the impact of age, genetics, disease, and formulation. The value of this capability in selecting and designing appropriate clinical studies, its implications for resource-sparing techniques, and a more holistic view of the application of PK across the preclinical/clinical divide are considered. Finally, some attention is given to the positioning of PBPK within the drug development and approval paradigm and its future application in truly personalized medicine.

Overview

Integrity signals

Registry

Crossref · 10.1146/annurev-pharmtox-010510-100540

Cites

199 of 199 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

2 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Citations

Cites

Show all 199 references

Research works printed but not linked: 10

  1. Teorell T., 1937, Arch. Int. Pharmacodyn. Ther., 57, 202
  2. Turner D, 2006, Drug Metab. Rev., 38, 162
  3. Webborn PJ, 2007, Xenobiotica, 37, 1090
  4. Gertz M, 2008, Drug Metab. Rev., 40, 92
  5. Rodgers T, 2006, Drug Metab. Rev., 38, 83
  6. Tucker GT., 1992, Int. J. Clin. Pharmacol. Ther. Toxicol., 30, 550
  7. Shou M., 2005, Curr. Opin. Drug Discov. Dev., 8, 66
  8. Einolf HJ., 2007, Xenobiotica, 37, 1257
  9. 10.1177/0091270003252519 · doi:10.1177/0091270003252519 · Paper page
  10. 167. 2008. EMEA workshop on modeling in paediatric medicines . http://www.ema.europa.eu/meetings/conferences/1415apr08.htm

Cited by

See all 662

Metadata

Authors
Rowland, M., Peck, C., & Tucker, G.
Affiliations
  • University of Manchester (GB)
  • University of California, San Francisco (US)
  • Royal Hallamshire Hospital (GB)
Venue
Annual Review of Pharmacology and Toxicology
Published
2011-02-10
Volume
51
Issue
1
Pages
45-73
ISSN
  • 0362-1642 (ISSN-L)
  • 1545-4304
OpenAlex
W2109530280
Cited by
662
References
199
Citations by year
2026: 41 · 2025: 27 · 2024: 28 · 2023: 19 · 2022: 46 · 2021: 39 · 2020: 37 · 2019: 39 · 2018: 32 · 2017: 40 · 2016: 50 · 2015: 58 · 2014: 50 · 2013: 67 · 2012: 55
FWCI
9.37
Type
journal article
Language
en
Open access
closed
Locations
  • The Annual Review of Pharmacology and Toxicology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmaceutical studies and practices
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
  • Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Clinical Trials
Keywords
physiologically based pharmacokinetic modeling, drug development, regulatory science, drug clearance, drug distribution, drug absorption, drug-drug interactions, in vitro-in vivo extrapolation, clinical trial design, personalized medicine, drug approval
MeSH terms
Animals, Clinical Trials as Topic, Computer Simulation, Drug and Narcotic Control, Drug Interactions, Pharmaceutical Preparations, Humans, Models, Biological, Pharmacokinetics, Drug Design, Drug Approval, Precision Medicine

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Physiologically-Based Pharmacokinetics in Drug Development and Regulatory Science. https://app.cochat.ai/papers/10.1146/annurev-pharmtox-010510-100540
The paper
Rowland, M., Peck, C., & Tucker, G. (2011). Physiologically-Based Pharmacokinetics in Drug Development and Regulatory Science. Annual Review of Pharmacology and Toxicology. https://doi.org/10.1146/annurev-pharmtox-010510-100540

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.